Factor IXa specific antibodies displaying factor VIIIa like activity
US7297336B2 · kind B2 · utility
2Cited by
5References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 12, 2003 |
| Grant date | Nov 20, 2007 |
| Priority date | — |
| Expiry date | Jul 16, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ligands such as antibodies that can bind factor IX/factor IXa and increase the procoagulant activity of factor IXa (FIXa), pharmaceutical compositions containing such ligands, methods for treating patients afflicted with blood coagulation with such ligands, and a nucleic acid that encodes, or a cell that expresses such ligands, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.